NICE and NHS England announce plan to enable innovative tech to be adopted quicker

23 May 2024 - NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies ...

Read more →

Early impact of the Inflation Reduction Act on drug discovery

6 March 2024 - Despite the concerns of the biopharma industry, the Inflation Reduction Act has been enacted and with it, ...

Read more →

Be thankful for high drug prices

4 February 2024 - If Americans weren’t overcharged, we wouldn’t have innovative treatments. ...

Read more →

New medical treatments will use genetic scissors, and other clever tricks

13 November 2023 - New medicines to treat sickle cell disease and beta thalassaemia, two genetic blood disorders, will make headlines ...

Read more →

MHRA supports launch of Innovate UK’s first of its kind initiative to fund new regulatory science and innovation networks

14 December 2023 - Applications are now open for academic institutions wishing to bid for funding to collaborate with others to ...

Read more →

Statement from President Joe Biden on FDA approval of gene therapies to treat sickle cell disease

8 December 2023 - As we’ve seen throughout our history, when the US Government invests in innovation, we can achieve breakthroughs ...

Read more →

A decade of health innovation: the impact of new medicines on patient health and the implications for NICE’s size of benefit multiplier

6 October 2023 - This study aimed to estimate the incremental health benefits of pharmaceutical innovations approved between 2011 and 2021 ...

Read more →

New payment models are needed to finance new advanced treatments

29 September 2023 - Pricing and subsidy methods and processes need to be developed to address the challenges that arise when ...

Read more →

The Inflation Reduction Act will lead to fewer new medicines

11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...

Read more →

Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say

13 April 2023 - If courts affirm US District Judge Matthew Kacsmaryk’s decision to suspend the FDA’s approval, it could make ...

Read more →

iOnctura awarded UK's MHRA Innovation Passport for entry into innovative licensing and access pathway

28 March 2023 -  iOnctura today announces that the innovative medicine designation, the Innovation Passport, has been awarded for roginolisib, ...

Read more →

The value of medical innovation versus industry rewards

10 March 2023 - This article provides systematic evidence on the share of the value of health generated by drugs and ...

Read more →

Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices.

10 March 2023 - By law, Medicare will have to take a medication’s efficacy and its research and development costs ...

Read more →

Areteia Therapeutics granted ILAP designation from UK MHRA for oral dexpramipexole for eosinophilic asthma

23 February 2023 - Areteia Therapeutics today announced that the UK’s MHRA has granted an Innovation Passport under the Innovative Licensing ...

Read more →

Testing a hypothesis: can we promote both innovation and affordability of drugs?

16 February 2023 - This week’s announcement by the CMS to test new payment models which promote both pharmaceutical access and ...

Read more →